III度肥胖与SWOG S1203研究中初治年轻急性髓系白血病患者总生存期的关联
研究纳入SWOG S1203中729例年龄≤60岁初治急性髓系白血病患者,分析体重指数与结局的关联。III度肥胖与早期死亡率升高(p=0.004)及多因素分析中更差的总生存期相关(HR 2.48,95%CI 1.62-3.80,对照正常体重)。异基因造血干细胞移植后,III度肥胖仍与更差的总生存期相关(HR 2.37,95%CI 1.24-4.54,对照正常体重)。
要点
- III度肥胖与初治年轻AML患者早期死亡风险升高相关(p=0.004)。
- 多因素分析中III度肥胖者总生存期较正常体重者差(HR 2.48,95%CI 1.62-3.80)。
- 异基因造血干细胞移植后III度肥胖仍与更差总生存期相关(HR 2.37,95%CI 1.24-4.54)。
核心结论
- III度肥胖与初治年轻急性髓系白血病患者早期死亡风险升高及更差的总生存期相关。
- III度肥胖与异基因造血干细胞移植后更差的总生存期相关。
- 作者认为这些发现凸显III度肥胖在急性髓系白血病中的独特风险,并强调需进一步研究以更好地描述该患者群体。
研究设计与样本
- 研究基于SWOG S1203试验,纳入年龄≤60岁初治急性髓系白血病患者729例,分析体重指数与结局的关联。
主要发现
- III度肥胖与早期死亡率升高相关(p=0.004)。
- 多因素分析中,III度肥胖者总生存期较正常体重者差(HR 2.48,95%CI 1.62-3.80)。
- 异基因造血干细胞移植后,III度肥胖者总生存期较正常体重者差(HR 2.37,95%CI 1.24-4.54)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
There has been ongoing debate on the association between obesity and outcomes in acute myeloid leukemia (AML). Currently few studies have stratified outcomes by class I obesity, class II obesity, and class III obesity, and a more nuanced understanding is becoming increasingly important with the rising prevalence of obesity. We examined the association between body mass index (BMI) and outcomes in previously untreated AML in younger patients (age ≤60) enrolled in SWOG S1203 (n = 729). Class III obesity was associated with an increased rate of early death (p = 0.004) and worse overall survival (OS) in multivariate analysis (hazard ratio (HR) 2.48, 95% confidence interval (CI) 1.62-3.80 versus normal weight). Class III obesity was also associated with worse OS after allogeneic hematopoietic cell transplant (HR 2.37, 95% CI 1.24-4.54 versus normal weight). These findings highlight the unique risk of class III obesity in AML, and the importance of further investigation to better characterize this patient population.
引用
- Zhang MY, Othus M, McMillen K, et al. Association between class III obesity and overall survival in previously untreated younger patients with acute myeloid leukemia enrolled on SWOG S1203. Leukemia. 2024. PMID: 38830960. doi:10.1038/s41375-024-02288-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。